The anti-tumor effects of human immunodeficiency virus protease inhibitors: ready for real time?
Stebbing
Justin
J
Bower
Mark
M
D000818:Animals; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D006801:Humans; D007150:Immunohistochemistry; D019469:Indinavir / Q000494:pharmacology; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism; D061965:Matrix Metalloproteinase Inhibitors; D051379:Mice; D009369:Neoplasms / Q000098:blood supply / Q000473:pathology / Q000517:prevention & control*; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000517:prevention & control*; D019258:Saquinavir / Q000494:pharmacology; D023041:Xenograft Model Antitumor Assays
D017320:HIV Protease Inhibitors; D061965:Matrix Metalloproteinase Inhibitors; D019469:Indinavir; D020778:Matrix Metalloproteinase 2; D019258:Saquinavir